Effects of Lycopene Attenuating Injuries in Ischemia and Reperfusion

Oxid Med Cell Longev. 2022 Oct 7:2022:9309327. doi: 10.1155/2022/9309327. eCollection 2022.

Abstract

Tissue and organ ischemia can lead to cell trauma, tissue necrosis, irreversible damage, and death. While intended to reverse ischemia, reperfusion can further aggravate an ischemic injury (ischemia-reperfusion injury, I/R injury) through a range of pathologic processes. An I/R injury to one organ can also harm other organs, leading to systemic multiorgan failure. A type of carotenoid, lycopene, has been shown to treat and prevent many diseases (e.g., rheumatoid arthritis, cancer, diabetes, osteoporosis, male infertility, neurodegenerative diseases, and cardiovascular disease), making it a hot research topic in health care. Some recent researches have suggested that lycopene can evidently ameliorate ischemic and I/R injuries to many organs, but few clinical studies are available. Therefore, it is essential to review the effects of lycopene on ischemic and I/R injuries to different organs, which may help further research into its potential clinical applications.

Publication types

  • Review

MeSH terms

  • Antioxidants* / pharmacology
  • Carotenoids / pharmacology
  • Carotenoids / therapeutic use
  • Humans
  • Ischemia
  • Lycopene / pharmacology
  • Lycopene / therapeutic use
  • Male
  • Reperfusion
  • Reperfusion Injury* / pathology

Substances

  • Antioxidants
  • Carotenoids
  • Lycopene